Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Equity Residential
EQR
$24.3B
| $82.5M | 0.07% |
1,402,241
+1,046,923
| +295% | +$64.9M |
|
302
Mercado Libre
MELI
$95.6B
| $81.9M | 0.07% |
83,100
+13,000
| +19% | +$9.75M |
|
|
WUBA
303
DELISTED
58.com Inc
WUBA
| $81.8M | 0.07% |
1,516,412
+1,031,100
| +212% | +$53.2M |
|
304
AvalonBay Communities
AVB
$25.9B
| $81.7M | 0.07% |
528,214
+386,600
| +273% | +$61.2M |
|
305
Shenandoah Telecom
SHEN
$731M
| $81.6M | 0.07% |
1,655,500
-6,200
| -0.4% | -$314K |
|
306
Public Service Enterprise Group
PEG
$37.7B
| $81.5M | 0.07% |
1,657,185
-293,000
| -15% | -$14.6M |
|
307
Vistra
VST
$49.5B
| $81.4M | 0.07% |
4,372,151
+1,365,160
| +45% | +$25.7M |
|
308
Medpace
MEDP
$16.7B
| $81.2M | 0.07% |
873,420
+53,732
| +7% | +$4.57M |
|
309
Coca-Cola Femsa
KOF
$23B
| $81.2M | 0.07% |
1,852,705
+118,500
| +7% | +$4.99M |
|
310
Xcel Energy
XEL
$48.8B
| $81.2M | 0.07% |
1,298,594
-2,893,879
| -69% | -$182M |
|
|
MODN
311
DELISTED
MODEL N, INC.
MODN
| $81M | 0.07% |
2,330,844
-67,700
| -3% | -$1.97M |
|
312
Smith & Wesson
SWBI
$641M
| $80.9M | 0.07% |
4,893,191
+1,103,118
| +29% | +$10.2M |
|
313
Perdoceo Education
PRDO
$1.95B
| $80.3M | 0.07% |
5,041,395
+54,600
| +1% | +$781K |
|
314
Idacorp
IDA
$8.2B
| $80.2M | 0.07% |
917,399
-218,400
| -19% | -$19.7M |
|
315
Clearway Energy Class C
CWEN
$7.19B
| $80.1M | 0.07% |
3,474,975
+185,600
| +6% | +$3.93M |
|
316
Wayfair
W
$14.1B
| $79.9M | 0.07% |
404,500
+169,500
| +72% | +$25.4M |
|
317
Workiva
WK
$3.72B
| $79.6M | 0.07% |
1,487,300
-10,300
| -0.7% | -$422K |
|
318
Black Hills Corp
BKH
$5.62B
| $79M | 0.07% |
1,393,523
-351,900
| -20% | -$21.3M |
|
|
AIV
319
Aimco
AIV
$379M
| $77.9M | 0.07% |
15,529,986
-14,578,965
| -48% | -$72.2M |
|
320
TJX Companies
TJX
$170B
| $77.8M | 0.07% |
1,539,202
+802,202
| +109% | +$40.3M |
|
321
FirstCash
FCFS
$9.1B
| $77.2M | 0.07% |
1,144,386
+167,800
| +17% | +$11.8M |
|
322
Honeywell
HON
$72.7B
| $76.5M | 0.07% |
561,587
+285,303
| +103% | +$37.8M |
|
|
LMNX
323
DELISTED
Luminex Corp
LMNX
| $76.4M | 0.07% |
2,349,142
+36,440
| +2% | +$1.15M |
|
324
Clean Harbors
CLH
$16.6B
| $76M | 0.07% |
1,267,635
-235,000
| -16% | -$13.1M |
|
325
Workday
WDAY
$43B
| $75.8M | 0.07% |
404,700
+325,400
| +410% | +$52.6M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.